Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1

Neuropharmacology

Volumn 41, Issue 4, 2001, Pages 443-453

  Choi, Bok Hee ^a   Choi, Jin Sung ^a   Yoon, Shin Hee ^a   Rhie, Duck Joo ^a   Min, Do Sik ^a   Jo, Yang Hyeok ^a   Kim, Myung Suk ^a   Hahn, Sang June ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Fluoxetine; Kv3.1; Metabolites; Norfluoxetine; Open channel block

Indexed keywords

FLUOXETINE; NORFLUOXETINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION;

ANIMAL CELL; ARTICLE; CHANNEL GATING; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; FEMALE; INTRACELLULAR RECORDING; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL;

ALGORITHMS; ANIMALS; BRAIN; CLONING, MOLECULAR; FLUOXETINE; NEURONS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; RATS; SEROTONIN UPTAKE INHIBITORS; SHAW POTASSIUM CHANNELS;

EID: 0034866127     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(01)00088-0     Document Type: Article

References (51)

1. Comparative pharmacokinetics of selective serotonin reuptake inhibitors: A look behind the mirror
2. 1A receptors
3. Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5
4. + currents
5. Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells
6. Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3
7. Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR)
8. Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells
9. Block of human cardiac Kv1.5 channels by loratadine: Voltage-, time- and use-dependent block at concentrations above therapeutic levels
10. + channels in sustained high-frequency firing of fast-spiking neocortical interneurons
11. Modulation of ionic currents in isolated canine and human jejunal circular smooth muscle cells by fluoxetine
12. Anticonvulsant effect of fluoxetine in humans
13. Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels
14. Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)
15. + channel in T cells
16. Inhibition by nystatin of Kv1.3 channels expressed in Chinese hamster ovary cells
17. Inhibition by fluoxetine of voltage-activated ion channels in rat PC12 cells
18. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches
19. + current in projecting neurons from the globus pallidus
20. Pharmacokinetics of selective serotonin reuptake inhibitors
21. Electrophysiological and pharmacological characterization of a mammalian Shaw channel expressed in NIH 3T3 fibroblasts
22. Human brain fluoxetine concentrations
23. Serum fluoxetine and norfluoxetine concentrations and antidepressant response
24. In vivo 19F spin relaxation and localized spectroscopy of fluoxetine in human brain
25. + channel diversity in the mammalian central nervous system
26. Antiepileptic drug mechanisms of action
27. Block by fluoxetine of volume-regulated anion channels
28. Determination of the antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC with ultraviolet detection
29. + channels by antidepressant drugs
30. The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin
31. Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation
32. Expression of the mRNAs for the Kv3.1 potassium channel gene in the adult and developing rat brain
33. Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats
34. Effect of Prozac on whole cell ionic currents in lens and corneal epithelia
35. + channel cloned from human heart
36. Localization of a highly conserved human potassium channel gene (NGK2-KV4; KCNC1) to chromosome 11p15
37. Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds
38. Contributions of Kv3 channels to neuronal excitability
39. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding
40. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel: Functional analysis after stable mammalian cell culture expression
41. A rapidly activating and slowly inactivating potassium channel cloned from human heart
42. Determinants of antiarrhythmic drug action: Electrostatic and hydrophobic components of block of the human cardiac hKv 1.5 channel
43. The pharmacologic profile of fluoxetine
44. Effect of fluoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1)
45. Class III antiarrhythmic effects of zatebradine: Time-, state-, use-, and voltage-dependent block of hKv1.5 channels
46. Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats
47. Contribution of the Kv3.1 potassium channel to high-frequency firing in mouse auditory neurones
48. + channels in the rat central nervous system
49. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication
50. Ionic blockage of sodium channels in nerve
51. Inhibition of neuronal Kv potassium currents by the antidepressant drug, fluoxetine